A regional prospective survey of RSV bronchiolitis.

被引:20
作者
Grimaldi, M
Cornet, B
Milou, C
Gouyon, JB
机构
[1] Hop Enfants, Serv Pediat 2, F-21034 Dijon, France
[2] CHU Dijon, Cellule Evaluat Reseau Perinatal Bourgogne, F-21034 Dijon, France
来源
ARCHIVES DE PEDIATRIE | 2002年 / 9卷 / 06期
关键词
bronchiolitis; respiratory syncitial virus; human antibodies; monoclonal; risk factors; child; hospitalization;
D O I
10.1016/S0929-693X(01)00923-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This prospective study was designed to identify risk factors associated with admission in pediatric intensive care units (PICU) among infants hospitalized for treatment of RSV induced bronchiolitis. This study was population-based and was conducted in Burgundy, a French region with 1800 000 inhabitants where passive immunoprophylaxis for RSV bronchiolitis was not set up at the time of the study. Results - From December 1st 1999 to April 30th 2000, 484 infants were hospitalized for RSV bronchiolitis in Burgundy. 19.6% were born prematurily (gestational age [GA] below 37 weeks) and at admission, 68.3% had a postnatal age below six months (mean=5 +/- 5.9 months; median value=3 months). The duration of hospitalization was 7.3 +/- 12.4 days (median value=6 days). Among the 484 infants, 31 (6.4%) needed admission in PICU, eight needed mechanical ventilation (1.7%) and one died (0.2%.). Univariate analysis identified anamnestic risk factors associated with admission in PICU: prematurity; low birth weight, past history of neonatal respiratory distress syndrome (RDS); mechanical ventilation for RDS treatment; bronchopulmonary dysplasia (BPD) and congenital heart disease. Multivariate analysis identified three independent factors associated with an increased risk for admission in PICU: GA below 32 weeks; RDS and congenital heart disease. Conclusion - This study suggests that population at risk for severe RSV bronchiolitis with PICU admission should include all very preterm infants with RDS whatever the outcome of RDS (with or without BPD). These epidemiological data could be helpful to set up indications for passive immunoprophylaxis of RSV induced bronchiolitis. (C) 2002 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:572 / 580
页数:9
相关论文
共 42 条
[1]  
[Anonymous], 1998, Pediatrics, V102, P1211
[2]  
BOURRILLON A, 2000, PEDIAT COLLECTION PR, P497
[3]   Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid [J].
Boyce, TG ;
Mellen, BG ;
Mitchel, EF ;
Wright, PF ;
Griffin, MR .
JOURNAL OF PEDIATRICS, 2000, 137 (06) :865-870
[4]   Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab [J].
Canfield, SD ;
Simoes, EAF .
PEDIATRIC ANNALS, 1999, 28 (08) :507-+
[5]   Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons [J].
Carbonell-Estrany, X ;
Quero, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (09) :874-879
[6]   Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation:: a prospective study [J].
Carbonell-Estrany, X ;
Quero, J ;
Bustos, G ;
Cotero, A ;
Doménech, E ;
Figueras-Aloy, J ;
Fraga, JM ;
García, LG ;
García-Alix, A ;
Del Río, MG ;
Krauel, X ;
Sastre, JBL ;
Narbona, E ;
Roqués, V ;
Hernández, SS ;
Zapatero, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (07) :592-597
[7]  
Connor E, 1997, PEDIATRICS, V99, P93
[8]  
CORNET B, 2000, 6 JOURN FRANC RECH N
[9]  
CUNNINGHAM CK, 1991, PEDIATRICS, V88, P527
[10]  
Floret D, 2001, ARCH PEDIAT S1, V8, P70